FC
TGTX icon

FORA Capital’s TG Therapeutics TGTX Stock Holding History

FORA Capital’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$457K Buy
8,320
+1,050
+14% +$43K 0.03% 282
2026
Q1 		$241K Buy
+7,270
New +$217K 0.02% 383
2021
Q1 		– Sell
-33,343
Closed -$1.74M – 1091
2020
Q4 		$1.74M Buy
+33,343
New +$1.13M 0.26% 87
2020
Q3 		– Sell
-4,473
Closed -$87K – 977
2020
Q2 		$87K Sell
4,473
-6,087
-58% -$98K 0.03% 527
2020
Q1 		$104K Buy
+10,560
New +$133K 0.02% 601

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

FORA Capital's TGTX Position: Q2 2026 in Review

FORA Capital increased its TG Therapeutics (TGTX) stake by 14% in Q2 2026, buying an estimated $43K and bringing the position to 8,320 shares worth $457K. The position accounts for 0.03% of the portfolio, ranked #282.

FORA Capital first reported a position in TGTX in Q1 2020 and has held it in 5 quarters since. The position peaked at $1.74M in Q4 2020. 428 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • FORA Capital held 8,320 shares of TG Therapeutics worth $457K as of Q2 2026.
  • FORA Capital bought 1,050 TG Therapeutics shares in Q2 2026, an estimated $43K.
  • TG Therapeutics made up 0.03% of FORA Capital's portfolio in Q2 2026, its #282 holding.
  • FORA Capital first reported a position in TG Therapeutics in Q1 2020 and has held it in 5 quarters since.
  • FORA Capital's TG Therapeutics position peaked at $1.74M in Q4 2020.
  • 428 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.